Device and method to facilitate safe, adhesion-free surgical closures

ABSTRACT

Surgical devices and methods are provided for preventing the formation of post-operative adhesions. In one device, an envelope of bioabsorbable material defines at least one opening, and a layer of bioabsorbable adhesion-preventing material is disposed on an exterior surface of the envelope. A rigid or semi-rigid barrier member is at least partially disposed in a space inside the envelope, without adhering to the envelope such that the barrier member can be pulled out of the envelope through the opening. In another device, a rigid or semi-rigid barrier member is removably attached to a layer of bioabsorbable adhesion-preventing material by a controlled adhesive. In another device, a rigid or semi-rigid bioabsorbable barrier member, such as compressed cellulose, is attached to a layer of bioabsorbable adhesion-preventing material. The envelope of bioabsorbable material may include cellulose or oxidized regenerated cellulose. The adhesion-preventing material may include chemically modified sodium hyaluronate and carboxymethylcellulose.

CROSS REFERENCE TO RELATED APPLICATION

This application claims priority to earlier filed U.S. ProvisionalPatent Application No. 61/392,168, filed on Oct. 12, 2010, and U.S.patent application Ser. No. 13/229,381, filed on Sep. 9, 2011, thedisclosures of which are hereby incorporated by reference, in theirentireties.

FIELD OF THE INVENTION

The present invention generally relates to surgical medical devices forretracting tissue, preventing post-operative adhesions of tissue, andmethods for same in closures of surgical incisions.

BACKGROUND

Two problems frequently encountered during the closure of surgicalincisions of the abdomen are risk of injury to the bowel and thepostoperative formation of adhesions to the abdominal wall.

Bowel injury leads to significant risk of infection, poor wound healing,hernia formation, and death. Bowel injury may be undetected at the timeof surgery, leading to leakage of intestinal content into the abdominalcavity with resulting infection. If not diagnosed and treated promptly,this type of bowel injury carries a high risk of peritonitis, poor woundhealing, hernia formation, and possible death. A mechanical barrierplaced within the abdominal cavity prior to surgical closure of theabdominal wound reduces the risk of bowel injury during closure.Currently, surgeons occasionally utilize various barrier type devicesduring the closure of the abdomen to reduce the risk of bowel injury.These devices may be rigid such as a flat steel surgical retractor.Semi-rigid devices made of rubber or plastic are also utilized for thispurpose, examples of which are shown in U.S. Pat. Nos. 4,964,417 and4,747,393. These devices are not bioabsorbable and must be removed priorto completion of the surgical closure of the abdomen and thereforeultimately do not reduce the risk of postoperative adhesions. Surgicalclosure of the abdomen performed with the assistance of these currentlyavailable devices carries a significant risk of postoperative adhesionformation which may result in bowel obstruction.

Postoperative adhesions are the most frequent cause of small bowelobstruction, a common condition with significant morbidity andmortality, often requiring surgical intervention. The majority of thesepatients suffer obstruction due to intra-abdominal adhesions. Theseadhesions are the result of scar formation frequently associated withprior abdominal surgery. Bowel obstruction due to abdominal adhesionscauses pain, vomiting, and may lead to gangrene of the bowel. Bowelobstruction due to adhesions frequently requires surgical treatmentwhich may lead to a recurrent cycle of scar formation, obstruction, andsurgery. A product which prevents the development of adhesions betweenthe bowel and abdominal wall may be placed within the abdominal cavityprior to surgical closure of abdomen. Such a product may be a prosthesismade of silicone elastomer and/or polypropylene mesh fabric, such asdisclosed in U.S. Pat. No. 5,593,441. Such a device however is notbioabsorbable. Currently, surgeons occasionally utilize various adhesionpreventing materials during the closure of the abdomen to reduce therisk of postoperative adhesions. Products known to be effective in theprevention of adhesions include chemically modified sodium hyaluronateand carboxymethylcellulose, such as provided in SEPRAFILM® brandadhesion barrier manufactured by Genzyme Corporation, Cambridge, Mass.However, these materials are difficult to apply, being extremelyfriable, and having a tendency to stick to any surgical instrument oncewetted after contacting tissue. Such a material also generally isprovided as a thin layer or coating of material which is easilypenetrated and therefore does not reduce the risk of injury to the bowelor other underlying tissue during closure of a surgical incision.

There currently exists no device which addresses all of theaforementioned problems during the closure of a surgical incision, suchas in abdominal surgery. Efforts to employ current adhesion-preventingmaterials with current barrier devices leads to displacement of theadhesion-preventing material, rendering it ineffective. There remains aneed therefore for a surgical device and method which reliably preventsinjury to the bowel or viscera during closure of a surgical incision,and/or reduces or prevents postoperative surgical adhesions.

SUMMARY OF THE INVENTION

The foregoing needs are met, to a great extent, by the presentinvention, wherein in some embodiments a surgical medical device andmethod that is capable of overcoming the disadvantages described hereinat least to some extent is provided. The device facilitates the safeclosure of surgical incisions in the abdominal cavity with the capacityto prevent the formation of postoperative adhesions. For example, thedevice combines a barrier function which serves to protect the bowel orviscera from injury during surgical closure of the abdomen with deliveryof a product which prevents formation of adhesions postoperatively. Thedevice may also be employed on other parts of the body, such as in theclosure of thoracic incisions to prevent lung injury and adhesionformation to the lung. The device is easily utilized, safe, and costeffective.

In accordance with a first embodiment of the invention, a surgicaldevice includes an envelope of bioabsorbable material having a firstsheet connected to a second sheet and defining at least one openingbetween said sheets at a first end of the envelope. A layer ofbioabsorbable adhesion-preventing material is disposed on at least thefirst sheet on an exterior surface of the envelope. A rigid orsemi-rigid barrier member is at least partially disposed between thefirst and second sheets in a space inside the envelope defined betweenthe first and second sheets. The barrier member is disposed in theenvelope without adhering to the first and second sheets such that thebarrier member can be pulled out of the envelope through the opening. Inone embodiment, the envelope is an elongate, substantially planar-shapedmember having two longer peripheral edge portions and two shorterperipheral edge portions and defines only one opening at one of theshorter edge portions on the first end of the envelope. In anotherembodiment, the first and second sheets are connected to each other atrespective peripheral portions to define the envelope and said oneopening, such that a second end of the envelope which is opposite to thefirst end is closed, the barrier member being inserted into the envelopeto span inside the envelope from the first end to the second end. In oneor more preferred embodiments, the adhesion-preventing material includeschemically modified sodium hyaluronate and carboxymethylcellulose. Inone or more preferred embodiments, the first sheet and second sheet ofthe envelope are made of cellulose or oxidized regenerated cellulose.

In accordance with another aspect of the present invention, a method ofpreventing adhesion of tissues following a surgical closure includesdisposing a surgical device at the site of an intended surgical closure.The surgical device includes an envelope of bioabsorbable materialhaving a first sheet connected to a second sheet and defining at leastone opening between said sheets at a first end of the envelope. A layerof bioabsorbable adhesion-preventing material is disposed on the firstsheet on an exterior surface of the envelope. The adhesion-preventingmaterial is placed or disposed on tissue underlying the site of theintended closure. A rigid or semi-rigid barrier member is at leastpartially disposed between the first and second sheets in a space insidethe envelope defined between the first and second sheets. The barriermember is disposed in the envelope without adhesion to the first andsecond sheets such that the barrier member can be pulled out of theenvelope through the opening. In the method, after the surgical deviceis placed at the site of the intended surgical closure, the surgicalclosure is performed towards completion. Prior to completion of thesurgical closure, the barrier member is pulled from the envelope out ofthe surgical device and away from the closure. The surgical closure isthen completed leaving the envelope and adhesion-preventing materialinside the closure. In one embodiment of the method, the envelopedefines only one opening, and the first and second sheets are connectedto each other at respective peripheral portions to define the envelopeand one opening, such that a second end of the envelope which isopposite to the first end is closed, and the barrier member is insertedinto the envelope to span completely across the envelope from the firstend to the second end. In one or more preferred embodiments, theadhesion-preventing material includes chemically modified sodiumhyaluronate and carboxymethylcellulose. In one or more preferredembodiments, the first sheet and second sheet are made of cellulose oroxidized regenerated cellulose.

In accordance with another embodiment of the present invention, asurgical device includes a rigid or semi-rigid barrier member having anelongate, substantially planar shape. A layer of bioabsorbableadhesion-preventing material is coupled to an exterior surface of therigid or semi-rigid barrier member by a controlled adhesive memberdisposed between the barrier member and the adhesion-preventing materialThe controlled adhesive layer can be removed from the layer ofadhesion-preventing material to release the barrier member from thelayer of adhesion-preventing material. In a preferred embodiment, theadhesion-preventing material includes chemically modified sodiumhyaluronate and carboxymethylcellulose.

In accordance with still another aspect of the present invention, amethod of preventing adhesion of tissues following a surgical closureincludes disposing a surgical device at the site of an intended surgicalclosure, which device includes a rigid or semi-rigid barrier memberhaving an elongate, substantially planar shape. A layer of bioabsorbableadhesion-preventing material is coupled to an exterior surface of therigid or semi-rigid barrier member by a controlled adhesive memberdisposed between the barrier member and the adhesion-preventing materialThe controlled adhesive layer can be removed from the layer ofadhesion-preventing material to release the barrier member from thelayer of adhesion-preventing material. In the method, theadhesion-preventing material is placed or disposed on tissue underlyingthe site of the intended closure. The surgical closure is then performedtowards completion. Prior to completion of the surgical closure, thebarrier member is separated from the layer of adhesion-preventingmaterial by pulling the controlled adhesive member to release thebarrier member from the layer of adhesion-preventing material. Thesurgical closure is then completed leaving the layer ofadhesion-preventing material inside the closure. In one or morepreferred embodiments, the adhesion-preventing material includeschemically modified sodium hyaluronate and carboxymethylcellulose.

In accordance with another embodiment of the present invention, asurgical device includes a rigid or semi-rigid barrier member made ofbioabsorbable compressed cellulose, the barrier member having anelongate, substantially planar shape. A bioabsorbableadhesion-preventing material is coupled to an exterior surface of therigid or semi-rigid barrier member. In one or more preferredembodiments, the adhesion-preventing material includes chemicallymodified sodium hyaluronate and carboxymethylcellulose.

In accordance with still another aspect of the present invention, amethod of preventing adhesion of tissues following a surgical closure isprovided. A surgical device is placed or disposed at the site of anintended surgical closure. The device includes a rigid or semi-rigidbarrier member made of bioabsorbable compressed cellulose, the barriermember having an elongate, substantially planar shape. A bioabsorbableadhesion-preventing material is coupled to an exterior surface of therigid or semi-rigid barrier member. The adhesion-preventing material isplaced or disposed on tissue underlying the site of the intendedclosure. The closure is completed leaving the barrier member and layerof adhesion-preventing material inside the closure. In one or morepreferred embodiments, the adhesion-preventing material includeschemically modified sodium hyaluronate and carboxymethylcellulose.

In accordance with another embodiment of the present invention, asurgical device includes a first layer of bioabsorbable material, and asecond layer of bioabsorbable adhesion-preventing material disposed onan exterior surface of the first layer, the second layer material beingdifferent from the first layer. In one or more embodiments, theadhesion-preventing material includes chemically modified sodiumhyaluronate and carboxymethylcellulose. In another embodiment, the firstand second layers are shaped substantially as a circle when fullyextended, and the device further includes an elongate tail of materialconnected to the first layer, to facilitate positioning of the device.The elongate tail may be connected to the center of the first layer. Inone or more embodiments, the first layer is made of cellulose oroxidized regenerated cellulose.

In accordance with still another aspect of the present invention, amethod of preventing adhesion of tissues following a surgical closure isprovided. A surgical device is placed or disposed at the site of anintended surgical closure. The device includes a first layer ofbioabsorbable material, and a second layer of bioabsorbableadhesion-preventing material disposed on an exterior surface of thefirst layer, the second layer material being different from the firstlayer. In the method, the second layer of adhesion-preventing materialis placed or disposed on tissue underlying the site of the intendedclosure, after which the closure is completed over the device. In one ormore embodiments, the adhesion-preventing material includes chemicallymodified sodium hyaluronate and carboxymethylcellulose. In anotherembodiment, the first and second layers are shaped substantially as acircle when fully extended, and the device further includes an elongatetail of material connected to the first layer, to facilitate positioningof the device. The elongate tail may be connected to the center of thefirst layer. In one or more embodiments, the first layer is made ofcellulose or oxidized regenerated cellulose.

As such, those skilled in the art will appreciate that the conceptionupon which this disclosure is based may readily be utilized as a basisfor the designing of other structures, methods and systems for carryingout the several purposes of the present invention. It is important,therefore, that the claims be regarded as including such equivalentconstructions insofar as they do not depart from the spirit and scope ofthe present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates a surgical device in accordance with an embodiment ofthe invention;

FIG. 2 illustrates a side view of the device as shown in FIG. 1 inaccordance with an embodiment of the invention;

FIG. 3 illustrates a device in accordance with an embodiment of theinvention inserted into a surgical incision, prior to closure of saidincision;

FIG. 4 illustrates a device in accordance with an embodiment of theinvention inserted into a surgical incision, during closure of saidincision;

FIG. 5 illustrates a device in accordance with an embodiment of theinvention inserted into a surgical incision, after closure of saidincision, and after the inner barrier element has been withdrawn fromthe device;

FIG. 6 illustrates a surgical device in accordance with anotherembodiment of the invention;

FIG. 7 illustrates a surgical device in accordance with anotherembodiment of the invention.

DETAILED DESCRIPTION

The present invention provides, in some embodiments, a surgical medicaldevice and method that facilitates the safe closure of surgicalincisions over inner body tissue viscera, and/or helps to prevent theformation of postoperative adhesions. The present invention serves as abarrier to protect the underlying or viscera from injury during surgicalclosure of the incision, while also providing a physical layer whichprevents formation of adhesions postoperatively. In an exemplaryembodiment, the device of the present invention combines a rigid orsemi-rigid flat barrier with a layer or sheath of product which preventsthe formation of postoperative adhesions. In a method in accordance withan embodiment of the invention, the device is placed into the abdominalcavity by the surgeon prior to closure of the abdominal surgical woundover the abdominal viscera. The surgeon proceeds to close the abdominallayers in the standard fashion. Prior to completion of the surgicalclosure, the rigid or semi-rigid portion of the device is removed,leaving within the abdominal cavity the product which prevents adhesionformation to the abdominal wall. The device can be sterile. The devicecan be designed for single use.

The invention will now be described with reference to the drawingfigures, in which like reference numerals refer to like partsthroughout.

FIG. 1 illustrates aspects of a surgical device 100 in accordance with afirst embodiment of the invention. The device 100 includes an envelope101 made of two overlying flat layers or sheets defining at least oneopening 110 on one side of the envelope 101. The envelope 101 maytherefore include a first sheet 102 which is connected to a second sheet103. The sheets may be connected to each other in any fashion, such asby stitching, adhesive, bonding, or molding. The sheets may also bedirectly produced or manufactured to form the envelope 101 having the atleast one opening 110. In the embodiment shown in FIG. 1, the sheet 102is connected or bonded to sheet 103 at their respective perimeters orperipheral portions, save for the edges which define opening 110. In oneembodiment, an end 120 of envelope 101 is closed, which end 120 isopposite to an end defining opening 110.

The device 100 further includes a rigid or semi-rigid barrier device ormember 104 which is inserted or at least partially disposed in theenvelope 101. As used herein, a “barrier member” is any body whichpresents a generally impenetrable outer surface and/or which readilyprevents the puncture or passage of another body, such as a needle,through said barrier member body, at least without the application of asubstantial amount of force. As used herein, a “semi-rigid” member isany body which may readily bend or flex but which does not compress orshear like a fluid or gel. An example of a rigid device which may beutilized for barrier member 104 is a standard steel malleable retractorcommonly available as a surgical instrument. An example of a semi-rigiddevice is a disposable plastic or rubber visceral retractor alsocommonly available as a surgical instrument. The barrier member 104 maybe completely enclosed inside an interior space within the envelope 101such as shown in FIG. 1, or may be partially disposed inside saidinterior space. The barrier member 104 may completely fill the interiorspace, and may extend along the entire length of the envelope from afirst end 111 to a second end 112, or may be sized to define or leavesome spacing between the barrier member 104 and the boundaries of theinterior space defined by envelope 101.

The envelope 101 made of sheets or layers 102, 103 may be made of amaterial which prevents the formation of post-operative adhesions.Alternatively, in an exemplary embodiment, an additional layer 105 ofadhesion-preventing material may be applied to one or both of sheets102, 103, as illustrated in FIG. 2. All components of the device 100 maybe sterile. The envelope 101, including each of sheets 102 and 103, andany additional layer such as layer 105, is preferably biocompatible andbioabsorbable. In a preferred embodiment of the invention, sheets 102,103 are made of a material which will not adhere to the inner barriermember 104, in order to facilitate withdrawal of the rigid or semi-rigidbarrier member 104 out of the envelope 101 of the device 100 prior tocompletion of the surgical closure. In this regard, the inner barriermember 104 is not attached to sheets 102, 103, or envelope 101 ingeneral, except for a minimal friction fit which holds the parts ofassembly 100 together prior to application into a surgical incision. Inan embodiment, the sheets 102, 103 may be made of cellulose or oxidizedregenerated cellulose. In an embodiment, the adhesion-preventingmaterial formed in sheets 102 or 103, or within layer 105, may includechemically modified sodium hyaluronate and carboxymethylcellulose, oranother suitable adhesion preventing material which is alsobioabsorbable and biocompatible, such as biologic glues or gels. Inalternative embodiments, the adhesion preventing material, such as usedin layer 105, may include other compounds or materials used inconjunction with either sodium hyaluronate or carboxymethylcellulose,separately or in combination. In an exemplary embodiment, the chemicallymodified sodium hyaluronate and carboxymethylcellulose material may be abioresorbable, translucent adhesion barrier composed of two anionicpolysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose(CMC), each of which has been chemically modified with the activatingagent 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC),such as provided in SEPRAFILM® brand adhesion barrier materialmanufactured by Genzyme Corporation, Cambridge, Mass. Possible othermaterials which may be considered adhesion-preventing for use in thepresent invention include omega-3 fatty acid impregnated or coatedmaterials. Layer 105 may be stitched, bonded, or otherwise connected oradhered to at least sheet 103. Another layer of adhesion-preventingmaterial (not shown) may also be applied or disposed over sheet 102.

In the embodiment illustrated in FIG. 1, the envelope 101 may preferablybe an elongate, substantially planar-shaped member having two longerperipheral edge portions 121, 122 and two shorter peripheral edgeportions 123, 124 and which defines only one opening 110 at short edgeportion 123 on first end 111 of the envelope 101. In this regard, theenvelope may be substantially rectangular shaped, although any planarshape may be embodied in the invention.

In using the invention during closure of a surgical incision, it isimportant that the planar area spanned by the invention adequately coverthe span or area of tissue underlying and around the incision wherepost-operative adhesions may occur. As such the device 100 must besufficiently long to span at least as long as any desired incision, butmust also be wide enough to cover both the areas into which surgicaltools or instruments (such as suture needles) may be used to effectclosure of the incision, so that the device 100 adequately protects theunderlying tissue via the barrier member 104. The width of the devicemust also be sufficient to provide the intended protection againstpost-operative tissue adhesions. Accordingly, a preferred aspect ratio(defined herein as length over width) of the planar assembly of theinvention 100 and/or envelope 101 may range from 2 to 10, while a morepreferred aspect ratio may range from 3 to 5.

In an embodiment, the first and second sheets 102, 103 of envelope 101are connected to each other at respective peripheral portions,demarcated at least by longer edge portions 121 and 122, to define theenvelope 101 and said opening 110, as well as the space inside theenvelope 101 into which the barrier member 104 is disposed. In theembodiment shown in FIG. 1, a second end 112 of the envelope 101 whichis opposite to the first end 111 is closed. In an embodiment, thebarrier member 104 can be disposed in the envelope 101 to extend fromthe first end to the second end of said envelope, to span substantiallythe entire length of the envelope. In other embodiments, each of firstsheet 102 and/or second sheet 103 may extend past any point ofconnection between said sheets, such that the envelope 101 defines atleast an inner space or pocket for receiving the inner barrier member104, but one or more portions of the sheets of bioabsorbable materialand any layer of bioabsorbable adhesion-preventing material disposedthereon extend outwards, similar to a planar peripheral skirt aroundenvelope 101, to provide a larger area to be covered by device 100,thereby enabling the device 100 to help prevent post-operative adhesionsover a wider area of tissue.

The device 100 may further include a means for retracting or pulling theinner barrier member 104 out of the envelope 101. In one embodiment astring or cord 130 may be attached to one end of the barrier member 104which can be pulled by a ring or other grip member 131 at an end of cord130 which is disposed outside any incision in which the device 100 isplaced. Other suitable means for retracting may also be used, such as,by example, an elongated handle, ribbon, or chain.

The present invention also provides a method of preventing adhesion oftissues following a surgical closure. As used herein, a “surgicalclosure” shall mean any closure of an opening or incision during asurgical or medical procedure on any human or mammalian body. In apreferred embodiment, the method of the invention includes the initialstep of disposing a surgical device at the site of an intended surgicalclosure, such as shown in FIG. 3. In FIG. 3, the device 100 is insertedover the viscera inside an open incision 199. Layer 105, made ofadhesion-preventing material as discussed herein, is disposed on top ofexposed visceral organs or tissue underlying the site of the intendedclosure. The surgical closure is then performed towards completion, asshown in FIG. 4, such as by suturing the incision closed under standardsurgical practice with a suture 191 and suture needle 192. As can beseen in FIG. 4, while the incision 199 is being closed, distal portions151 of the device 100 opposite to opening 110, including portions ofenvelope 101 and inner barrier member 104, may remain inside the closurewithin the body. While the surgical closure is performed, the barriermember 104 acts as a shield to the tissue underlying the device 100, tohelp prevent accidental injury to such tissue by surgical instruments,such as suture needle 192. Prior to completion of the surgical closure,the barrier member 104 is pulled using means 131 out from the envelope101, generally in the direction “A” shown in FIG. 4, away from site ofthe surgical closure. The completed closure 199 c eventually has theenvelope 101 and adhesion-preventing material 105 attached to saidenvelope 101 left inside the closure within the body. The envelope 101and adhesion-preventing material 105 are bioabsorbable and eventuallydissolve and are absorbed by the body. The adhesion-preventing material105 helps to prevent formations of adhesions between the underlyingviscera and any overlying tissue which has been closed or suturedtogether, such as the abdominal wall.

FIG. 6 illustrates a surgical device in accordance with anotherembodiment of the invention. Device 200 includes a rigid or semi-rigidbarrier member 204 having an elongate, substantially planar shape. Alayer of bioabsorbable adhesion-preventing material 205 is coupled to anexterior surface of the rigid or semi-rigid barrier member 204 by acontrolled adhesive member 201 disposed between the barrier member 204and the adhesion-preventing material 205. The controlled adhesive layer201 can be pulled out from between the barrier member 204 and the layerof adhesion-preventing material 205 to release the barrier member 204from the layer of adhesion-preventing material 205. In one embodiment,the barrier member 204 can be a rigid, flat device, and theadhesion-preventing material 205 can be bonded to one side of the rigidor semi-rigid flat device. In one embodiment, the adhesion-preventingmaterial 205 can include chemically modified sodium hyaluronate andcarboxymethylcellulose. In other embodiments, another suitable adhesionpreventing material which is also bioabsorbable and biocompatible can beused, including biologic glues or gels. The barrier member 204 can be arigid or malleable steel retractor. In one embodiment, theadhesion-preventing material 205 may only be disposed to cover oneexterior side of the barrier member 204. In an embodiment as shown inFIG. 6, the layer of adhesion-preventing material 205 may extend in areabeyond the perimeter of the barrier member 204, to form a peripheralskirt 220 about the barrier member 204, which peripheral extension orskirt may form any suitable shape for use in closure of a surgicalincision, in order to help prevent the formation of post-operativeincisions. The controlled adhesive 201 may be any suitable adhesivematerial which provides enough adhesion between member 204 and layer 205to enable the device 200 to be handled for proper insertion andpositioning inside the site of an intended surgical closure, while beingcapable of being removed from layer 205, without significantly affectingthe integrity of layer 205, to enable the barrier member 204 to bereadily separated or released from the layer 205. The controlledadhesive may be incorporated into an element, such as an adhesiveimpregnated or coated yarn or thread. In one embodiment, as is shown inFIG. 6, the controlled adhesive layer 201 may be shaped as an elongate,thin, string-like formation, which can be pulled by a gripping means231.

In an embodiment of the invention, a method of preventing adhesion oftissues following a surgical closure includes disposing surgical device200 at the site of an intended surgical closure, such as in, forexample, the abdomen, the adhesion-preventing material 205 beingdisposed on viscera or tissue underlying the site of the intendedclosure. The surgical closure is performed towards completion, but priorto completion of the surgical closure, the barrier member 204 isseparated from the layer of adhesion-preventing material 205 by removingthe controlled adhesive member 201 from the layer of adhesion-preventingmaterial 205 to release the barrier member 204 from the layer ofadhesion-preventing material 205. The surgical closure is then completedand leaving the layer of adhesion-preventing material 205 inside theclosure, which is eventually dissolved. In order to be most usefulduring a surgical closure, the aspect ratio of the device 200 and/orlayer 205 including skirt 220 may range from 2 to 10, while a morepreferred aspect ratio may range from 3 to 5.

FIG. 7 illustrates a surgical device in accordance with anotherembodiment of the invention. The device 300 includes a rigid orsemi-rigid barrier member 304 made of bioabsorbable compressedcellulose, or similar bioabsorbable, biocompatible substance. In anembodiment, the barrier member 304 may have an elongate, substantiallyplanar shape. A bioabsorbable adhesion-preventing material 305 is bondedor coupled to at least one side or an exterior surface of the barriermember 304. In one embodiment, the adhesion-preventing material 305 mayonly be disposed to cover one exterior side of the barrier member 304.In an embodiment as shown in FIG. 7, the layer of adhesion-preventingmaterial 305 may extend in area beyond the perimeter of the barriermember 304, to form a peripheral skirt 320 about the barrier member 304,which peripheral extension or skirt may form any suitable shape for usein closure of a surgical incision, in order to help prevent theformation of post-operative incisions. In an embodiment, theadhesion-preventing material 305 can include chemically modified sodiumhyaluronate and carboxymethylcellulose. In other embodiments, anothersuitable adhesion preventing material which is also bioabsorbable andbiocompatible can be used, including biologic glues or gels.

The present invention can also have applications where a rigid orsemi-rigid barrier member such as member 304 is not practical when usedfor certain types of surgical incisions. One such application arelaparoscopic surgical procedures, where the incisions to be closed arerelatively small. The present invention therefore also includes one ormore embodiments of a device, and methods of use of same, which includesa first layer of bioabsorbable material, and a second layer ofbioabsorbable adhesion-preventing material disposed on an exteriorsurface of the first layer, the second layer being made of a materialdifferent from the first layer. In one or more embodiments, theadhesion-preventing material includes chemically modified sodiumhyaluronate and carboxymethylcellulose, but may include another suitableadhesion preventing material which is also bioabsorbable andbiocompatible, such as biologic glues or gels. In an exemplaryembodiment, the first and second layers are shaped substantially as acircle when fully extended, although any shape is possible. The firstand second layers can be configured to fold into a form with minimalcross-sectional area, so that the device can be inserted through anendoscopic or other narrow bore surgical instrument, such as forexample, instruments used in laparoscopic surgery. The device furthercan include an elongate tail of material connected to the first layer,to facilitate positioning of the device, such as after it is insertedinto the site of a surgical closure through an endoscopic instrument. Inan embodiment, the tail can be connected to the center of the firstlayer, such as when the first layer is shaped substantially as a circle.In one or more embodiments, the first layer is made of cellulose oroxidized regenerated cellulose, although other suitable bioabsorbablematerials may be used.

In an embodiment of the invention, a method of preventing adhesion oftissues following a surgical closure includes disposing device 300 atthe site of an intended surgical closure, the adhesion-preventingmaterial 305 being disposed on tissue underlying the site of theintended closure. The surgical closure may then be completed leaving theentire device 300, including barrier member 304 and the layer ofadhesion-preventing material 305 inside the closure, both of which arebioabsorbable and may eventually dissolve harmlessly in the body. Inorder to be most useful during a surgical closure, the aspect ratio ofthe device 300 and/or layer 305 including skirt 320 may range from 2 to10, while a more preferred aspect ratio may range from 3 to 5.

The many features and advantages of the invention are apparent from thedetailed specification, and thus, it is intended by the appended claimsto cover all such features and advantages of the invention which fallwithin the true spirit and scope of the invention. Further, becausenumerous modifications and variations will readily occur to thoseskilled in the art, it is not desired to limit the invention to theexact construction and operation illustrated and described, andaccordingly, all suitable modifications and equivalents may be resortedto falling within the scope of the invention.

The invention claimed is:
 1. A surgical device, comprising: an envelopecomprising a first layer of bioabsorbable material having a first sheetconnected to a second sheet and defining at least one opening betweensaid sheets at a first end of the envelope, wherein the bioabsorbablematerial of the first layer includes cellulose or oxidized regeneratedcellulose; the envelope further comprising a second, additional layer,made of bioabsorbable adhesion-preventing material, disposed on at leastthe first or second sheet of the first layer on an exterior surface ofthe envelope wherein the bioabsorbable adhesion-preventing material ofthe second, additional layer comprises chemically modified sodiumhyaluronate and carboxymethylcellulose, or omega-3 fatty acidimpregnated material, or omega-3 fatty acid coated material, or acombination thereof; and a rigid or semi-rigid planar barrier member,which does not compress like a fluid, at least partially disposedbetween the first and second sheets in a space inside the envelopedefined between the first and second sheets, the barrier member beingdisposed in the envelope without adhesion to the first and second sheetssuch that the barrier member can be pulled out of the envelope throughthe opening without adhering to the envelope, the rigid or semi-rigidbarrier member being configured to prevent puncture or passage of aneedle through said barrier member, and wherein the second, additionallayer of adhesion-preventing material is prevented from sticking to, orbeing displaced by, the barrier member, due to the first or second sheetof the first layer of the envelope being disposed between the barriermember and the second, additional layer of adhesion-preventing material.2. The device of claim 1, wherein the envelope is an elongate,substantially planar-shaped member having two longer peripheral edgeportions and two shorter peripheral edge portions and wherein theenvelope defines only one opening at one of the shorter peripheral edgeportions on the first end of the envelope.
 3. The device of claim 2,wherein the first and second sheets are connected to each other atrespective peripheral portions to define the envelope and said oneopening, a second end of the envelope which is opposite to the first endbeing closed, and wherein the barrier member is disposed in the envelopeto extend from the first end to the second end of said envelope.